Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 38,345 | 0 | 0 | 0 | 0 |
| Gross Profit | 38,345 | N/A | N/A | N/A | N/A |
| Operating Expenses | 71,546 | 69,362 | 68,040 | 63,158 | 57,683 |
| Operating Income | -33,201 | -69,362 | -68,040 | -63,158 | -57,683 |
| Other Income | 186 | -65,368 | 1,843 | 2,184 | 3,203 |
| Pre-tax Income | -33,015 | -134,730 | -66,197 | -60,974 | -54,480 |
| Net Income Continuous | -33,015 | -134,730 | -66,197 | -60,974 | -54,480 |
| Net Income | $-33,015 | $-134,730 | $-66,197 | $-60,974 | $-54,480 |
| EPS Basic Total Ops | -0.25 | -1.08 | -0.52 | -0.53 | -0.50 |
| EPS Basic Continuous Ops | -0.25 | -1.08 | -0.52 | -0.53 | -0.50 |
| EPS Diluted Total Ops | -0.25 | -1.08 | -0.52 | -0.53 | -0.50 |
| EPS Diluted Continuous Ops | -0.25 | -1.08 | -0.52 | -0.53 | -0.50 |
| EBITDA(a) | $-29,372 | $-65,705 | $-64,813 | $-61,043 | $-55,846 |